Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis

Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis

Background. Atrial fibrillation (AF) is the most common serious cardiac rhythm disturbances and is responsible for substantial morbidity and mortality in general population. Hypertension is the most prevalent and potentially modifiable risk factor for AF. This study is aimed at evaluating the effect...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Haotian Ma, Hongcheng Jiang, Jing Feng, Yong Gan
Μορφή:	Άρθρο
Γλώσσα:	English
Έκδοση:	Hindawi-Wiley 2021-01-01
Σειρά:	Cardiovascular Therapeutics
Διαθέσιμο Online:	http://dx.doi.org/10.1155/2021/6628469

Παρόμοια τεκμήρια

Angiotensin&nbsp;II receptor blockers in the prevention of complications from atrial fibrillation
ανά: Gerald V Naccarelli, κ.ά.
Έκδοση: (2009-09-01)

Angiotensin II receptor blockers and cardiovascular protection: Focus on left ventricular hypertrophy regression and atrial fibrillation prevention
ανά: Cesare Cuspidi, κ.ά.
Έκδοση: (2008-02-01)

A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention
ανά: Ji-Guang Wang
Έκδοση: (2009-07-01)

Long-term observation of fibrillation cycle length in patients under angiotensin II receptor blocker therapy for chronic atrial fibrillation
ανά: Jun Kishihara, κ.ά.
Έκδοση: (2012-02-01)

Left Atrial Function in Different Modes of Heart-Rate Lowering Therapy with Beta-Blockers in Patients with Recurrent Atrial Fibrillation and Hypertension
ανά: E. V. Kokhan, κ.ά.
Έκδοση: (2021-07-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
ανά: O. M. Drapkina, κ.ά.
Έκδοση: (2014-07-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
ανά: O. M. Drapkina, κ.ά.
Έκδοση: (2014-07-01)

Demographic determinants and effect of pre-operative angiotensin converting enzyme inhibitors and angiotensin receptor blockers on the occurrence of atrial fibrillation after CABG surgery
ανά: Weiss Michael J, κ.ά.
Έκδοση: (2010-02-01)

Angiotensin‐Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but Do Not Prevent New‐Onset Atrial Fibrillation After Acute Myocardial Infarction
ανά: Gorav Batra, κ.ά.
Έκδοση: (2017-03-01)

Termination of Aconitine-Induced Atrial Fibrillation by the KACh-Channel Blocker Tertiapin: Underlying Electrophysiological Mechanism
ανά: Kazumasa Suzuki, κ.ά.
Έκδοση: (2014-01-01)

Lower heart rates and beta-blockers are associated with new-onset atrial fibrillation
ανά: Nicole Habel, κ.ά.
Έκδοση: (2023-06-01)

Effect of β-blockers on the risk of atrial fibrillation in patients with acute myocardial infarction
ανά: Antonio Eduardo Pesaro, κ.ά.
Έκδοση: (2010-01-01)

Calcium channel blockers, more than diuretics, enhance vascular protective effects of angiotensin receptor blockers in salt-loaded hypertensive rats.
ανά: Eiichiro Yamamoto, κ.ά.
Έκδοση: (2012-01-01)

Organization of atrial fibrillation using a pure sodium channel blocker: Implications of rotor ablation therapy
ανά: Tadafumi Nanbu, κ.ά.
Έκδοση: (2023-06-01)

Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question
ανά: Hyun Woong Lee
Έκδοση: (2014-12-01)

Correction: Calcium Channel Blockers, More than Diuretics, Enhance Vascular Protective Effects of Angiotensin Receptor Blockers in Salt-Loaded Hypertensive Rats
Έκδοση: (2013-01-01)

Comparative effect of angiotensin II type I receptor blockers and calcium channel blockers on laboratory parameters in hypertensive patients with type 2 diabetes
ανά: Nishida Yayoi, κ.ά.
Έκδοση: (2012-05-01)

The haemodynamic changes associated with treatment of new-onset atrial fibrillation with amiodarone or beta blockers
ανά: Bedford, J, κ.ά.
Έκδοση: (2021)

Decreased Mortality with Beta-Blocker Therapy in HFpEF Patients Associated with Atrial Fibrillation
ανά: Yanhua Yang, κ.ά.
Έκδοση: (2020-01-01)

Acute Management of Paroxysmal Atrial Fibrillation with Intravenous Flecainide plus Oral Beta-Blockers
ανά: Athanasios Kartalis, κ.ά.
Έκδοση: (2024-06-01)

Which beta-blocker should be used for the prevention of postoperative atrial fibrillation in cardiac surgery? A multi-treat
ανά: Mohamed Zeinah, κ.ά.
Έκδοση: (2016-06-01)

Novel beta-blocker pretreatment prevents alcohol-induced atrial fibrillation in a rat modelKey Findings
ανά: Hebah Hassan, BS, κ.ά.
Έκδοση: (2020-06-01)

The use of angiotensin receptor blockers in dementia prevention
ανά: Jordana de Araujo Müller, κ.ά.
Έκδοση: (2023-09-01)

Effect of angiotensin receptor-neprilysin inhibitor on atrial electrical instability in atrial fibrillation
ανά: Tianyu Zhu, κ.ά.
Έκδοση: (2022-12-01)

Efficacy of β blockers in patients with heart failure plus atrial fibrillation: An individual-patient data meta-analysis
ανά: Kotecha, D, κ.ά.
Έκδοση: (2014)

Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.
ανά: Kotecha, D, κ.ά.
Έκδοση: (2014)

Association between the use of renin-angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction
ανά: Akif Arslan, κ.ά.
Έκδοση: (2016-01-01)

Effects of Angiotensin Receptor Blockers on Apelin and Visfatin in Hypertension
ανά: Mina Mohammed, κ.ά.
Έκδοση: (2024-06-01)

Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis.
ανά: Yen-Chung Lin, κ.ά.
Έκδοση: (2017-01-01)

COMBINATION OF DIRECT RENNIN INHIBITOR - ALISKIREN, ANGIOTENSIN II RECEPTOR BLOCKER - VALSARTAN, AND CALCIUM CHANNEL BLOCKER - AMLODIPINE, IN THERAPY OF HYPERTENSIVE PATIENT WITH GOUT (CASE REPORT)
ανά: O. V. Dralova, κ.ά.
Έκδοση: (2016-01-01)

Effect of angiotensin II receptor blockers and calcium antagonists on cognition
ανά: O. D. Ostroumova, κ.ά.
Έκδοση: (2016-12-01)

β-blockers and risk of all-cause mortality in patients with chronic heart failure and atrial fibrillation—a meta-analysis
ανά: Tianyu Xu, κ.ά.
Έκδοση: (2019-06-01)

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
ανά: M. A. Maksimova, κ.ά.
Έκδοση: (2015-09-01)

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
ανά: M. A. Maksimova, κ.ά.
Έκδοση: (2015-09-01)

Real-world efficacy of fimasartan vs. other angiotensin receptor blockers in combination with calcium channel blockers: a nationwide cohort study
ανά: Huijin Lee, κ.ά.
Έκδοση: (2024-10-01)

Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic
ανά: Volpe M, κ.ά.
Έκδοση: (2012-06-01)

Differential Effects in Cardiovascular Markers between High-Dose Angiotensin II Receptor Blocker Monotherapy and Combination Therapy of ARB with Calcium Channel Blocker in Hypertension (DEAR Trial)
ανά: Kenichiro Kinouchi, κ.ά.
Έκδοση: (2011-01-01)

Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up
ανά: Han Saem Jeong, κ.ά.
Έκδοση: (2021-01-01)

Lowering serum homocysteine in H-type hypertensive patients with atrial fibrillation after radiofrequency catheter ablation to prevent atrial fibrillation recurrence
ανά: Youzheng Dong, κ.ά.
Έκδοση: (2022-09-01)

Managing postoperative atrial fibrillation after open-heart surgery using transdermal β1 blockers
ανά: Kenji Yamamoto, κ.ά.
Έκδοση: (2023-04-01)